Bring in show music, please. >> Hi, I'm CNBC producer Katie Kramer. Today on Squawk Pod, the promise of a personalized cancer vaccine.We have the CEO of Madna, Stefan Bonscel. >> It's a big moment for medicine, big moment for patients. >> Milestone experimental results that could extend life for patients with the deadly diagnosis of melanoma.MK's Dr. . Dean Lee. We don't know if this is going to be 7 years, 9 years, but there's a chance that you have an increased ability to be disease-free and for a potenti ...

Well, we're following some major medical news today that could impact more than a million Americans living with or previously diagnosed with the deadliest form of skin cancer. Two pharmaceutical giants announcing today promising results from an experimental vaccine to treat melanoma. Now, according to Merc and Maderna, a combination of the vaccine and medication appear to stop the cancer from returning or spreading in high-risisk patients.NBC News health reporter Arya Bendix joining us now to talk about thi ...

Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Meanshttps://t.co/qrBUOQN8jO ...

Monetary Policy and Government Debt - The U.S. Treasury announced plans to double its liquidity support through buybacks of long-dated government debt from 2 billion to 4 billion dollars, aiming to improve market liquidity after 30-year yields reached a multi-year high of 5.30% [26][69][79] - The 30-year Treasury yield dropped by 8.6 to 9 basis points to trade around 5.20% following the buyback announcement [25][69] Retail and Consumer Sector - Target reported a second-quarter sales increase of 3.8% driven by traffic growth of 3.6%, alongside double-digit growth in snack sales, prompting the company to raise its full-year sales outlook despite supply chain and tariff pressures [123][126][127][157] - Lowe's cut its full-year forecast due to a sluggish housing market and a pressured DIY consumer, though shares rallied 4.5% as investors anticipated future tariff refunds and potential stabilization [2][4][49][133] Healthcare and Pharmaceutical Innovation - Moderna and Merck announced promising clinical trial results showing their personalized mRNA cancer vaccine cut the risk of melanoma recurrence, leading to a surge in stock value with Moderna's shares jumping nearly 96% and Merck tracking toward its best performance since 2009 [9][11][68][119][158] Automotive and Trade Dynamics - President Trump delayed 50% tariffs on Canadian goods for three days as the U.S. and Canada neared a tentative trade deal addressing barriers on autos, dairy, and alcohol, while Truecar noted a 50% drop in new car searches and a shift toward used cars and hybrids [27][29][170][171] Technology Infrastructure and Regional Backlash - Big tech companies faced growing bipartisan local opposition, resulting in 75 data center projects being blocked in the first three months of the year totaling 130 billion dollars, with Pennsylvania Governor Josh Shapiro becoming the latest official to restrict data center development [38][40][179]

A personalized vaccine developed by Moderna and Merck reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. @g0ingmad explains https://t.co/XSDJpoFUJs https://t.co/C1YpENKqgF ...

Breaking news this morning from pharma giants Madna and Merc. The companies say that an experimental vaccine treatment shows promise in preventing melanoma from returning or spreading in high-risisk patients. The mRNA vaccine was tested on people who had already had surgery to remove melanoma.The companies have not published those findings yet. They described it as a firstofits-kind breakthrough. ...

A record surge in Moderna’s shares delivered a $5 billion blow to short sellers who had bet that the vaccine maker’s years-long slump would continue. https://t.co/RQnUX5OfZ6 ...

Crypto things you might have missed:-@SECGov proposes Regulation Crypto Assets-Trump confirmed for crypto meeting-US Treasury doubles long-term buybacks-XRP sees lowest weekly close in 2 years-Robinhood says tokenization is a global supercycle-Moderna $MRNA up ~110% ...

If you could train your immune cells to be like hunting dogs, chasing the tumor, then you could unleash them. But not only could you unleash them, if you could entrain them to smell out that prey, that would be something. And so, in the last 10 years, that's what this result does.What Keytruda does is it's a key. It's a Keytruda. It unlocks the key to let the hound dogs out. Let the dogs out.But what's critical about the technology that Moderna has created is it's a personalized cancer treatment that allows ...

https://t.co/W1hL4JhXyyNone (@None):JUST IN: Moderna $MRNA surges 130% after cancer vaccine shows signs of preventing melanoma from spreading. https://t.co/YJcx9Bg0g3 ...